Breast Cancer Radiation-Induced Skin Toxicity Late Skin Toxicity Breast cancer, Radiotherapy, Tomotherapy, Radiation Injuries, Risk Factors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Review medical records, including diagnostic reports, treatment records, and radiotherapy plans. 2. Patients will be considered eligible for inclusion if they meet the following criteria: 2.1 Female breast cancer patients aged 18 years or older, who are able to read and write, are willing to participate in the study, and provide written informed consent. 2.2 Received post-operative radiotherapy entirely using helical tomotherapy techniques. 2.3 Treated within the study period February 2020 to December 2024.
Exclusion criteria
Exclusion criteria: 1. Did not complete radiotherapy according to the prescribed treatment plan. 2. Were lost to follow-up after completion of radiotherapy. 3. Had incomplete data that prevented outcome assessment according to the study endpoints. 4. Declined participation in the clinical evaluation or did not consent to the use of their data for further study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Late skin toxicity At follow up visits at least 3 months after completion of radiotherapy Late radiation induced skin toxicity assessed using RTOG EORTC scoring criteria | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors associated with late skin toxicity During study follow up period Clinical treatment and dosimetric factors analyzed using ordinal logistic regression and generalized ordered logistic regression | — |
Countries
Thailand
Contacts
Buddhachinaraj Phitsanulok Hospital